You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 6, 2025

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Haixia Shan1,2, Bo Wang1,3, Xiaodong Zhang1
1Key Laboratory for Experimental Teratology of the Ministry of Education, Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China.
Cullin 4B (CRL4B) enhances Hepatitis B virus (HBV) replication by stabilizing the HBx protein. This interaction inhibits HBx degradation, suggesting CRL4B as a potential therapeutic target for HBV infection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: